title: Raynaud’s phenomenon in a patient with schizophrenia and obsessive-compulsive disorder: a case report.
authors.forename: Sevda
authors.initials: S
authors.lastname: Korkmaz
authors.forename: Umut
authors.initials: U
authors.lastname: Işik
authors.forename: Hasan
authors.initials: H
authors.lastname: Korkmaz
mesh_terms: D017311:Amlodipine / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use; D002998:Clonazepam / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000627:therapeutic use; D018757:GABA Modulators / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000150:complications* / Q000188:drug therapy; D000077152:Olanzapine; D011928:Raynaud Disease / Q000150:complications* / Q000188:drug therapy; D012559:Schizophrenia / Q000150:complications* / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use
chemical_list: D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D018757:GABA Modulators; D014665:Vasodilator Agents; D005473:Fluoxetine; D001569:Benzodiazepines; D017311:Amlodipine; D002998:Clonazepam; D000077152:Olanzapine